RxDoctor Payments Data

Ian Duensing, MD

Adult Reconstructive Orthopaedic Surgery · Charlottesville, VANPI 1417341314

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.8%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 36.5% of the total. 2025 is the largest year on record at $52,783, more than ten times the $300 reported in 2019.

$82,527in general payments, 2019–2025

Across 119 payments — averaging $693.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$30K
  • Smith+Nephew$26K
  • Johnson & Johnson$16K
  • Depuy Synthes Products, Inc.$8K
  • Zimmer Biomet$2K
  • Stryker$517
  • plus $299 from 2 others
$36,590in research payments, 2019–2025

Across 3 payments — averaging $12,197 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$21K
  • Si-bone, Inc.$16K

What the payments were for

  • Consulting fees$45,22855%
  • Travel & lodging$4,4675%
  • Food & beverage$7,0669%
  • Education$25,76631%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,527 in reported general payments places this provider in the 80th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.

See all adult reconstructive orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$351,777
Medicare patients
522
Services billed
924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib18$409

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →